Further essentials of pharmacology for nurses
Description:
David Armstrong, Senior Lecturer, Northumbria University, UK
"This new book explains specific common disease processes including anatomy and physiology as well as the medications/drugs which may be used… It will be essential reading for pre-registration nursing students who want to build on their existing knowledge."
Margaret Dilger, Lecturer, University of Salford, UK
This user-friendly guide follows on from the bestselling book Essentials of Pharmacology for Nurses, and is written for pre-registration nursing students looking for an accessible guide to drug groups that goes beyond the essentials. It is simple and accessible and examines the next logical set of drug groups that nurses need to know. These include:
- Cardiovascular drugs
- Gastrointestinal drugs
- Drugs used in cancer
- Drugs used in nausea and vomiting
- Anaesthesia
- Fluids
- Topical medicines
- Multiple choice questions in every chapter and calculation tests
- Unique sections on ‘Complementary Therapies and Pharmacology’ and ‘Medicines Used on the Skin’
- Clinical tip boxes linking pharmacology to the role of the nurse or midwife
- Patient scenarios from a range of different clinical settings
Best prices to buy, sell, or rent ISBN 9780335243976
Frequently Asked Questions about Further essentials of pharmacology for nurses
The price for the book starts from $12.43 on Amazon and is available from 11 sellers at the moment.
If you’re interested in selling back the Further essentials of pharmacology for nurses book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Further essentials of pharmacology for nurses book, the best buyback offer comes from and is $ for the book in good condition.
The Further essentials of pharmacology for nurses book is in very low demand now as the rank for the book is 10,406,821 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.